A gene expression profiling approach assessing celecoxib in a randomized controlled trial in prostate cancer.
Tools
Tools
Tools
Sooriakumaran, P, Macanas-Pirard, P, Bucca, G, Henderson, A, Langley, SE, Laing, RW, Smith, CP, Laing, EE and Coley, HM (2009) A gene expression profiling approach assessing celecoxib in a randomized controlled trial in prostate cancer. Cancer Genomics Proteomics, 6 (2). 93 - 99. ISSN 1109-6535
![[img]](/style/images/fileicons/application_pdf.png)
| PDF Available under License : See the attached licence file. 100Kb | |
| PDF (licence) 32Kb |
Official URL: http://cgp.iiarjournals.org/content/6/2/93.short
Abstract
We performed a pilot study, looking at the COX-2 inhibitor celecoxib, on newly diagnosed prostate cancer patients in the neo-adjuvant setting using DNA microarray analysis.
| Item Type: | Article |
|---|---|
| Additional Information: | Copyright© 2009 International Institute of Anticancer Research (Dr. John G. Delinassios), All rights reserved. Reproduced here by permission of the publisher. |
| Uncontrolled Keywords: | Base Sequence, Cyclooxygenase Inhibitors, DNA Primers, DNA, Complementary, Gene Expression Profiling, Humans, Male, Oligonucleotide Array Sequence Analysis, Polymerase Chain Reaction, Prostatic Neoplasms, Pyrazoles, Single-Blind Method, Sulfonamides |
| Divisions: | Faculty of Health and Medical Sciences > Microbial and Cellular Sciences |
| ID Code: | 203293 |
| Deposited By: | Symplectic Elements |
| Deposited On: | 23 Apr 2012 09:43 |
| Last Modified: | 16 Feb 2013 15:48 |
Document Downloads
Repository Staff Only: item control page